Earnings Date
Oct 31
EPS
$-0.200
Quarterly Revenue
$67M
Annual Revenue (as of Sep 30)
$248.7M
Earnings History
Analyze the earnings history of Kiniksa Pharmaceuticals using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 02/27/2024 | AM | KNSA | Q4 | $0.06 | — | — | — | $61.88M | — | — | — | Get Alert |
| 10/31/2023 | AM | KNSA | Q3 | $3.18 | -$0.17 | -$0.20 | -17.65% | $99.14M | $64.45M | $67.05M | 4.03% | Get Alert |
| 07/25/2023 | AM | KNSA | Q2 | -$0.29 | -$0.17 | -$0.02 | 88.24% | $26.97M | $52.20M | $71.47M | 36.92% | Get Alert |
| 05/02/2023 | AM | KNSA | Q1 | -$0.36 | -$0.21 | -$0.18 | 14.29% | $32.19M | $46.58M | $48.34M | 3.79% | Get Alert |
| 02/28/2023 | AM | KNSA | Q4 | -$0.53 | -$0.23 | $0.06 | 126.09% | $18.75M | $45.11M | $61.88M | 37.18% | Get Alert |
| 11/01/2022 | AM | KNSA | Q3 | -$0.44 | $0.50 | $3.18 | 536.00% | $12.10M | $74.39M | $99.14M | 33.26% | Get Alert |
| 08/03/2022 | AM | KNSA | Q2 | -$0.61 | -$0.44 | -$0.29 | 34.09% | $7.70M | $28.55M | $26.97M | -5.53% | Get Alert |
| 05/03/2022 | AM | KNSA | Q1 | -$0.72 | -$0.41 | -$0.36 | 12.20% | $0.00 | $22.77M | $32.19M | 41.37% | Get Alert |
| 02/22/2022 | AM | KNSA | Q4 | -$0.79 | -$0.42 | -$0.53 | -26.19% | $0.00 | $20.72M | $18.75M | -9.53% | Get Alert |
| 11/01/2021 | AM | KNSA | Q3 | -$0.66 | -$0.65 | -$0.44 | 32.31% | $0.00 | $10.18M | $12.10M | 18.81% | Get Alert |
| 08/03/2021 | AM | KNSA | Q2 | -$0.65 | -$0.79 | -$0.61 | 22.78% | $0.00 | $3.97M | $7.70M | 94.06% | Get Alert |
| 05/04/2021 | AM | KNSA | Q1 | -$0.48 | -$0.80 | -$0.72 | 10.00% | $0.00 | $3.72M | $0.00 | -100.00% | Get Alert |
| 02/23/2021 | AM | KNSA | Q4 | -$0.58 | — | -$0.79 | — | $0.00 | — | $0.00 | — | Get Alert |
| 11/05/2020 | AM | KNSA | Q3 | -$0.49 | — | -$0.66 | — | $0.00 | — | $0.00 | — | Get Alert |
| 07/30/2020 | AM | KNSA | Q2 | -$0.68 | — | -$0.65 | — | $0.00 | — | $0.00 | — | Get Alert |
| 04/28/2020 | AM | KNSA | Q1 | -$1.27 | -$0.63 | -$0.48 | 23.81% | $0.00 | — | $0.00 | — | Get Alert |
| 02/26/2020 | AM | KNSA | Q4 | -$0.88 | — | -$0.58 | — | $0.00 | — | $0.00 | — | Get Alert |
| 10/28/2019 | PM | KNSA | Q3 | -$0.51 | — | -$0.49 | — | $0.00 | — | $0.00 | — | Get Alert |
| 08/12/2019 | AM | KNSA | Q2 | -$0.97 | -$0.72 | -$0.68 | 5.56% | $0.00 | — | $0.00 | — | Get Alert |
When is Kiniksa Pharmaceuticals (NASDAQ:KNSA) reporting earnings?
Kiniksa Pharmaceuticals (KNSA) is scheduled to report earnings on February 27, 2024. The last reported earnings were for reported on October 31, 2023 for Q3.
What were the latest earnings per share (EPS) for Kiniksa Pharmaceuticals (NASDAQ:KNSA)?
The Actual EPS was $-0.20, which missed the estimate of $-0.17.
What were Kiniksa Pharmaceuticals’s (NASDAQ:KNSA) revenues?
The Actual Revenue was $67M, which beat the estimate of $64.5M.
Browse earnings estimates, EPS, and revenue on all stocks.